CD24 (CD24 Molecule)

News alerts, weekly reports and conference planners

Entrez ID:

CD24 overexpression	Chronic Lymphocytic Leukemia	CD24 overexpression	Chronic Lymphocytic Leukemia	remibrutinib Resistant: C3 – Early Trials remibrutinib Resistant : C3	remibrutinib Resistant: C3 – Early Trials remibrutinib Resistant : C3
CD24 expression	Triple Negative Breast Cancer	CD24 expression	Triple Negative Breast Cancer	JQ-1 Resistant: C3 – Early Trials JQ-1 Resistant : C3	JQ-1 Resistant: C3 – Early Trials JQ-1 Resistant : C3
CD24 overexpression	Diffuse Large B Cell Lymphoma	CD24 overexpression	Diffuse Large B Cell Lymphoma	R-CHOP Sensitive: C3 – Early Trials R-CHOP Sensitive : C3	R-CHOP Sensitive: C3 – Early Trials R-CHOP Sensitive : C3
CD44 overexpression + CD24 underexpression	Esophageal Squamous Cell Carcinoma	CD44 overexpression + CD24 underexpression	Esophageal Squamous Cell Carcinoma	cisplatin + 5-fluorouracil Resistant: C3 – Early Trials cisplatin + 5-fluorouracil Resistant : C3	cisplatin + 5-fluorouracil Resistant: C3 – Early Trials cisplatin + 5-fluorouracil Resistant : C3

Associations(4)